Cargando…

Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer

Gastric cancer is the third leading cause of cancer mortality worldwide. Unfortunately, most gastric cancer cases are diagnosed in an advanced, non-curable stage and with a limited response to chemotherapy. Drug resistance is one of the most important causes of therapy failure in gastric cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riquelme, Ismael, Letelier, Pablo, Riffo-Campos, Angela L., Brebi, Priscilla, Roa, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813275/ https://www.ncbi.nlm.nih.gov/pubmed/27011182 http://dx.doi.org/10.3390/ijms17030424

Ejemplares similares

The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective
por: Riquelme, Ismael, et al.
Publicado: (2021)

Tools for Sequence-Based miRNA Target Prediction: What to Choose?
por: Riffo-Campos, Ángela L., et al.
Publicado: (2016)

Role of lncRNAs in the Development of an Aggressive Phenotype in Gallbladder Cancer
por: Pérez-Moreno, Pablo, et al.
Publicado: (2021)

Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma
por: Riquelme, Ismael, et al.
Publicado: (2023)

Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance
por: Reyes, María Elena, et al.
Publicado: (2020)

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer
por: Letelier, Pablo, et al.
Publicado: (2012)

Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
por: Buchegger, Kurt, et al.
Publicado: (2016)

Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer
por: Pérez-Moreno, Pablo, et al.
Publicado: (2022)

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers
por: Letelier, Pablo, et al.
Publicado: (2016)

Exploring the Genetic Diversity of Epstein–Barr Virus among Patients with Gastric Cancer in Southern Chile
por: Reyes, María Elena, et al.
Publicado: (2023)

Role of biochemical markers in the monitoring of COVID-19 patients
por: Letelier, Pablo, et al.
Publicado: (2021)

Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer
por: Buchegger, Kurt, et al.
Publicado: (2017)

Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
por: Viscarra, Tamara, et al.
Publicado: (2019)

Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells
por: León, Daniela, et al.
Publicado: (2020)

MiRNAs and miRNA Polymorphisms Modify Drug Response
por: Li, Mu-Peng, et al.
Publicado: (2016)

Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix
por: Saavedra, Kathleen P, et al.
Publicado: (2012)

miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance
por: Sbirkov, Yordan, et al.
Publicado: (2022)

A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses
por: Zanella, Louise, et al.
Publicado: (2019)

The functional sites of miRNAs and lncRNAs in gastric carcinogenesis
por: Wan, Xiangxiang, et al.
Publicado: (2015)

Functional miRNAs in breast cancer drug resistance
por: Hu, Weizi, et al.
Publicado: (2018)

Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers
por: Wu, Hua-Hsi, et al.
Publicado: (2014)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Emerging role of miRNAs in the regulation of ferroptosis
por: Mahmoudi-Lamouki, Reza, et al.
Publicado: (2023)

Identification of Aberrantly Expressed miRNAs in Gastric Cancer
por: Liu, Dan, et al.
Publicado: (2014)

Host miRNAs-microbiota interactions in gastric cancer
por: Yang, Yan, et al.
Publicado: (2022)

Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines
por: Mora-Lagos, Barbara, et al.
Publicado: (2020)

Workflow optimization in a clinical laboratory using Lean management principles in the pre-analytical phase
por: Letelier, Pablo, et al.
Publicado: (2021)

miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives
por: Gisel, Andreas, et al.
Publicado: (2014)

Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance
por: Santos, Patrick, et al.
Publicado: (2020)

Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer
por: Gong, Liu, et al.
Publicado: (2021)

Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma
por: Zhang, Xiaojing, et al.
Publicado: (2015)

miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation
por: Galloway, Dylan A., et al.
Publicado: (2016)

Emerging roles of exosomal miRNAs in diabetes mellitus
por: He, Xiaoyun, et al.
Publicado: (2021)

Editorial: Emerging roles of miRNAs in cardiovascular disease
por: Santovito, Donato, et al.
Publicado: (2023)

The Role and Expression of Angiogenesis-Related miRNAs in Gastric Cancer
por: Giuppi, Martina, et al.
Publicado: (2021)

Exosomal MiRNAs in Pediatric Cancers
por: Galardi, Angela, et al.
Publicado: (2019)

MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity
por: Lafourcade, Carlos, et al.
Publicado: (2016)

Emerging role of miRNAs, lncRNAs, and circRNAs in pregnancy-associated diseases
por: Fu, Xiaoxiao, et al.
Publicado: (2023)

miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance
por: Tavakoli Pirzaman, Ali, et al.
Publicado: (2023)

miRNAs and cancer
por: Wiemer, Erik A C
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_58dp4co2p64mvedo1nrd478rnn